People with health insurance will benefit, starting Friday, from more compensated prescription drugs. The list of drugs compensated from compulsory health insurance funds has been extended by 11 common international names.

In the list was included glimepiride, to treat diabetes and brimonidine/timolol, for the treatment of glaucoma, those drugs now being offered for free.

Multiple new prescription drugs will also be compensated on average by 70%: for management of hypertension- Telmisartan, for people over 65 treatment of hypertension and for left ventricular failure- Nebivolol,  to treat high blood pressure, heart failure, or stable coronary artery disease- Perindopril, for treating mild to severe congestive heart failure, left ventricular dysfunction- Carvedilol.

Two new compensated drugs are available for episodic treatment: Pantoprazole to treat certain stomach and esophagus problems, only for patients suffering from heart disease or diabetes, Pregabalin for treating neuropathic pain from diabetic peripheral neuropathy.

For adults, those drugs will be only partially compensated, on average with 70%. Children will receive those prescription drugs for free.

Another drug included in the list is Aceclofenac, for the relief of pain and inflammation in rheumatoid arthriti, compensated on average by 50%. 

Lercanidipine to treat high blood pressure to those tolerant to Amlodipine and Salmeterol xinafoate/ Fluticasone propionate for chronic obstructive pulmonary disease and bronchial asthma, will be compensated on average with 30%.

At the same time, three common international names of drugs, that were to this point prescribed in episodic treatment, will be prescribed for lasting treatment. Those are Valsartan for treatment of high blood pressure, congestive heart failure, Diclofenac for the treatment of rheumatoid arthritis, osteoarthritis and Allopurinol for patients who have gout.